Cardio-oncology in China

被引:4
|
作者
Sharma, K. [1 ]
Wang, Shanshan [1 ]
Liu, Ying [2 ]
Zhang, Yangli [2 ]
Liu, Tong [3 ]
Zhang, Qingling [3 ]
Zhong, Qiaoqing [4 ,5 ]
机构
[1] Official Cardiooncol Org China, Rainbow Ctr, CardioOncol, 201 Floor 2,Bldg B,Hechuan Rd 3051, Shanghai 201100, Peoples R China
[2] Dalian Med Univ, Dept Cardiol, Affiliated Hosp 1, 193 United Rd, Dalian 116021, Liaoning, Peoples R China
[3] Second Hosp Tianjin Med Univ, Tianjin Inst Cardiol, Dept Cardiol, Tianjin Key Lab Ion Mol Funct Cardiovasc Dis, 23 Pingjiang Rd, Tianjin 300211, Peoples R China
[4] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia, Crit Care & Pain Med Dept, Boston, MA 02215 USA
[5] Cent South Univ, Xiangya Hosp, Dept Cardiovasc Med, Changsha 410008, Peoples R China
关键词
Cardio-oncology; Multidisciplinary team; Evolvement of cardio-oncology; Knowledge Transfer Model; China;
D O I
10.1007/s11864-023-01123-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Opinion statementCardio-oncology is going under rapid development in various areas across an increasing number of provinces in China. However there are still a myriad of challenges that need to be overcome in order to ensure its gradual and consistent expansion. The Cardio-Oncology Knowledge Transfer Model (KTM) forms the basis to allow exponential development of effective cardio-oncology services. This would ensure the implementation of precision-based practice while dynamically evolving cardio-oncology to integrate both Western and Chinese medical practices to become an official clinical sub-speciality in its own right in China, for the ultimate benefit of the patient.
引用
收藏
页码:1472 / 1488
页数:17
相关论文
共 50 条
  • [41] Pharmacological Foundations of Cardio-Oncology
    Minotti, Giorgio
    Salvatorelli, Emanuela
    Menna, Pierantonio
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (01): : 2 - 8
  • [42] Heart and cancer: cardio-oncology
    Michel, Lars
    Rassaf, Tienush
    HERZ, 2024, 49 (02) : 111 - 117
  • [43] The role of ferroptosis in cardio-oncology
    Kai Hou
    Lin Liu
    Zhi-Hui Fang
    Wei-Xing Zong
    Daqiang Sun
    Zhigang Guo
    Lu Cao
    Archives of Toxicology, 2024, 98 : 709 - 734
  • [44] Hypertension management in cardio-oncology
    Essa, Hani
    Dobson, Rebecca
    Wright, David
    Lip, Gregory Y. H.
    JOURNAL OF HUMAN HYPERTENSION, 2020, 34 (10) : 673 - 681
  • [45] Birth and Maturation of Cardio-Oncology
    Bhatt, Deepak L.
    JACC: CARDIOONCOLOGY, 2019, 1 (01): : 114 - 116
  • [46] Cardio-oncology for the general cardiologist
    Tan, Li-Ling
    Lyon, Alexander Richard
    HEART, 2021, 107 (15) : 1254 - 1266
  • [47] Role of Imaging in Cardio-Oncology
    Avelar E.
    Strickland C.R.
    Rosito G.
    Current Treatment Options in Cardiovascular Medicine, 2017, 19 (6)
  • [48] Is Cardio-oncology Ready for Algorithms?
    Ewer, Steven M.
    EUROPEAN CARDIOLOGY REVIEW, 2018, 13 (01) : 62 - 63
  • [49] Hypertension management in cardio-oncology
    Hani Essa
    Rebecca Dobson
    David Wright
    Gregory Y. H. Lip
    Journal of Human Hypertension, 2020, 34 : 673 - 681
  • [50] The Role of Biomarkers in Cardio-Oncology
    Ananthan, Kajaluxy
    Lyon, Alexander R.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2020, 13 (03) : 431 - 450